Timentin and Dilaudid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Timentin (clavulanate potassium; ticarcillin disodium) and Dilaudid (hydromorphone hydrochloride). Common drug interactions include breast cancer metastatic among females and respiratory depression among males.

The phase IV clinical study analyzes what interactions people have when they take Timentin and Dilaudid. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Timentin?

Timentin has active ingredients of clavulanate potassium; ticarcillin disodium. eHealthMe is studying from 624 Timentin users. Check the latest studies of Timentin.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

On Jul, 10, 2026

16 people who take Timentin and Dilaudid together, and have interactions are studied.

Timentin and Dilaudid drug interactions.

What are the common drug interactions of Timentin and Dilaudid, by gender? *:

female:

Breast cancer metastatic
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Constipation
Decreased interest
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Deformity (disfigurement)
Discomfort
Dizziness
Dysgeusia (disorder of the sense of taste)
Dyspepsia (indigestion)

male:

Respiratory depression (respiration has a rate below 12 breaths)
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Jaundice cholestatic

What are the common drug interactions of Timentin and Dilaudid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Cardiac failure congestive
Death
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Febrile neutropenia (fever with reduced white blood cells)
Multi-organ failure (multisystem organ failure)
Pericardial effusion (fluid around the heart)
Pneumonia fungal
Renal failure acute (rapid kidney dysfunction)
Sepsis (a severe blood infection that can lead to organ failure and death)

40-49:

n/a

50-59:

Disseminated intravascular coagulation (systemic activation of blood coagulation)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Jaundice cholestatic
Pneumonia
Productive cough
Pyrexia (fever)

60+:

Alanine aminotransferase increased
Anxiety
Deformity (disfigurement)
Discomfort
Dizziness
Dysgeusia (disorder of the sense of taste)
Dyspepsia (indigestion)
Emotional distress
Gait disturbance
Gingivitis (inflammation of gums)

What are the existing conditions these people have? *

Stress And Anxiety: 9 people, 56.25%
Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 9 people, 56.25%
Breast Cancer: 9 people, 56.25%
White Blood Cell Count Abnormal: 1 person, 6.25%
Pneumonia: 1 person, 6.25%
Breast Cancer Female: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Timentin and Dilaudid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously